A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus

Antiviral Research

Volumn 62, Issue 1, 2004, Pages 21-25

  Paragas, Jason ^a   Whitehouse, Chris A ^a   Endy, Timothy P ^a,b   Bray, Mike ^a,c  

^a US Army Medical Research Institute of Infectious Diseases   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antiviral; Bunyavirus; Crimean Congo hemorrhagic fever virus; High throughput screening; Ribavirin; Tick borne disease

Indexed keywords

ANTIVIRUS AGENT; AZAURIDINE; RIBAMIDINE; RIBAVIRIN; SELENAZOFURIN; TIAZOFURIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG INHIBITION; DRUG SCREENING; DRUG SENSITIVITY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; NAIRO VIRUS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; VIRUS CULTURE; VIRUS INFECTION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; AZAURIDINE; CELL LINE; CERCOPITHECUS AETHIOPS; COLORING AGENTS; CRICETINAE; FIBROBLASTS; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HUMANS; MICROBIAL SENSITIVITY TESTS; NEUTRAL RED; ORGANOSELENIUM COMPOUNDS; PLAQUE ASSAY; RIBAVIRIN; RIBONUCLEOSIDES; STAINING AND LABELING; VERO CELLS; VIRUS REPLICATION;

ACARI; ANIMALIA; CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; DHORI VIRUS; NAIROVIRUS; ORTHOBUNYAVIRUS;

EID: 1542509354     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2003.11.006     Document Type: Article

References (22)

1. Baker R.O., Bray M., Huggins J.W. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res. 57:2003;13-23.
2. Borio L., Inglesby T., Peters C.J., Schmaljohn A.L., Hughes J.M., Jahrling P.B., Ksiazek T., Johnson K.M., Meyerhoff A., O'Toole T., Ascher M.S., Bartlett J., Breman J.G., Eitzen E.M. Jr., Hamburg M., Hauer J., Henderson D.A., Johnson R.T., Kwik G., Layton M., Lillibridge S., Nabel G.J., Osterholm M.T., Perl T.M., Russell P., Tonat K. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA. 287:2002;2391-2405.
3. Burney M.I., Saleen M., Webb P.A., Casals J. Nosocomial outbreak of viral hemorrhagic fever caused by Crimean hemorrhagic fever-Congo virus in Pakistan, January 1976. Am. J. Trop. Med. Hyg. 29:1980;941-947.
4. Fisher-Hoch S.P., Khan J.A., Mirza S., Khurshid M., McCormick J.B. Crimean Congo-haemorrhagic fever treated with ribavirin. Lancet. 346:1995;472-475.
5. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo haemorrhagic fever in Asia Europe and Africa. J. Med. Entomol. 15:1979;307-417.
6. Mardani M., Jahromi M.K., Naieni K.H., Zeinali M. The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran. Clin. Infect. Dis. 36:2003;1613-1618.
7. Morikawa S., Qing T., Xinqin Z., Saijo M., Kurane I. Genetic diversity of the M RNA segment among Crimean-Congo hemorrhagic fever virus isolates in China. Virology. 296:2002;159-164.
8. Nichol, S.T., 2001. Bunyaviruses. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, vol. 1, 4th ed. Lippincott Williams and Wikins, Philadephlia, pp. 1603-1633.
9. Papa A., Bozovi B., Pavlidou V., Papadimitriou E., Pelemis M., Antoniadis A. Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia. Emerg. Infect. Dis. 8:2002a;852-854.
10. Papa A., Ma B., Kouidou S., Tang Q., Hang C., Antoniadis A. Genetic characterization of the M RNA segment of Crimean Congo hemorrhagic fever virus strains, China. Emerg. Infect. Dis. 8:2002b;50-53.
11. Rubinstein S., Familletti P.C., Pestka S. Convenient assay for interferons. J. Virol. 37:1981;755-758.
12. Schwarz T.F., Nsanze H., Longson M., Nitschko H., Gilch S., Shurie H., Ameen A., Zahir A.R., Acharya U.G., Jager G. Polymerase chain reaction for diagnosis and identification of distinct variants of Crimean-Congo hemorrhagic fever virus in the United Arab Emirates. Am. J. Trop. Med. Hyg. 55:1996;190-196.
13. Shepherd A.J., Swanepoel R., Shepherd S.P., Leman P.A., Blackburn N.K., Hallert A.F. A nosocomial outbreak of Crimean-Congo hemorrhagic fever at Tygerberg Hospital. V. Virological and serological observations. S. Afr. Med. J. 68:1985;733.
14. Sidwell R.W., Huffman J.H., Barnard D.L., Pifat D.Y. Effects of ribamidine, a 3-carboxamidine derivative of ribavirin, on experimentally induced Phlebovirus infections. Antiviral Res. 10:1988;193-207.
15. Sidwell R.W., Huffman J.H., Barnard D.L., Smee D.F., Warren R.P., Chirigos M.A., Kende M., Huggins J. Antiviral and immunomodulating inhibitors of experimentally-induced Punto Toro virus infections. Antiviral Res. 25:1994;105-122.
16. Smee D.F., Gilbert J., Leonhardt J.A., Barnett B.B., Huggins J.H., Sidwell R.W. Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen. Antiviral Res. 20:1993;57-70.
17. Swanepoel R., Gill D.E., Shepherd A.J., Leman P.A., Mynhardt J.H., Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev. Infect. Dis. 11(Suppl. 4):1989;S794-S800.
18. Tang Q., Saijo M., Zhang Y., Asiguma M., Tianshu D., Han L., Shimayi B., Maeda A., Kurane I., Morikawa S. A patient with Crimean-Congo hemorrhagic fever serologically diagnosed by recombinant nucleoprotein-based antibody detection systems. Clin. Diagn. Lab. Immunol. 10:2003;489-491.
19. Tignor G.H., Hanham C.A. Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antiviral Res. 22:1993;309-325.
20. Vassilenko S.M., Vassilev T.L., Bozadjiev L.G., Bineva I.L., Kazarov G.Z. Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever. Lancet. 335:1990;791-792.
21. Watts, D.M., Ksiazek, T.G., Linthicum, K.J., Hoogstraal, H., 1988. Crimean-Congo hemorrhagic fever. In: Monath, T.P. (Ed.), The Arboviruses: Epidemiology and Ecology, vol. II. CRC Press, Boca Raton, pp. 177-222.
22. Watts D.M., Ussery M.A., Nash D., Peters C.J. Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Am. J. Trop. Med. Hyg. 41:1989;581-585.